SCHEMBL7103546

SCHEMBL7103546

CCOC(=O)C1=C(O)CCN(C(=O)OCc2ccccc2)C1.CCOC(=O)C1=C(OS(=O)(=O)C(F)(F)F)CCN(C(=O)OCc2ccccc2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 7/20 0.42
SIGMAR1 Q99720 7/20 0.42
CHRM5 P08912 2/20 0.40
HTR1A P08908 1/20 0.40
SLC6A2 P23975 1/20 0.40
HRH2 P25021 1/20 0.40
ADRA1D P25100 1/20 0.40
HTR1B P28222 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
HTR1E P28566 1/20 0.40
HRH1 P35367 1/20 0.40
HTR2B P41595 1/20 0.40
SLC6A3 Q01959 1/20 0.40
GAA P10253 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
PTGDR2 Q9Y5Y4 6/20 0.39
F13A1 P00488 1/20 0.39
TGM2 P21980 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4399041 0.95 TMEM97 (0.45) TMEM97SIGMAR1CHRM5HTR1ASLC6A2
SCHEMBL13382410 0.87 TMEM97 (0.46) TMEM97SIGMAR1PTGDR2SMN1; SMN2
SCHEMBL18767256 0.87 RAB9A (0.43) TMEM97SIGMAR1HTR1ASLC6A2HRH2
SCHEMBL4399188 0.87 TMEM97 (0.49) TMEM97SIGMAR1CHRM5HTR1ASLC6A2
SCHEMBL7197953 0.84 TMEM97 (0.39) TMEM97SIGMAR1CHRM5HTR1ASLC6A2
SCHEMBL3992432 0.79 ADORA1 (0.37) CHRM5GAATSHRCYP2C19CHRM2
SCHEMBL1901800 0.79 MEN1 (0.48) CHRM5CYP2C19CHRM2CHRM4CHRM1
SCHEMBL556981 0.79 ADORA1 (0.47) CHRM5GAACHRM2CHRM4CHRM1
SCHEMBL1082333 0.78 ESR1 (0.39) CHRM5TSHRCHRM2CHRM4CHRM1
SCHEMBL23924514 0.78 TMEM97 (0.46) TMEM97SIGMAR1PTGDR2L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed